Results: 1-12 |
Results: 12

Authors: ARNOLD JMO DAVIS BR NASH DT INSUL W LEWIS S KOHN RM GLASSER SP BELEW KM KIMMEL B SACKS FM
Citation: Jmo. Arnold et al., LIPID-LEVELS, ADHERENCE TO MEDICATION, BASE-LINE CHARACTERISTICS IN THE CHOLESTEROL AND RECURRENT EVENTS (CARE) STUDY, Journal of the American College of Cardiology, 31(2), 1998, pp. 89-89

Authors: BROWN L SESTIER F NASH DT CUDDY TE WILT TJ HOWARD J MOYE LA SIMPSON L SACKS FM
Citation: L. Brown et al., CORONARY RISK-FACTORS PREDICT RECURRENT CORONARY EVENTS AFTER MYOCARDIAL-INFARCTION, Circulation, 98(17), 1998, pp. 1691-1691

Authors: ARNOLD JMO DAVIS BR NASH DT INSULL W LEWIS S KOHN RM GLASSER SP BELEW KM KIMMEL B ZIMBALDI NC SACKS FM
Citation: Jmo. Arnold et al., INFLUENCE OF PATIENT ADHERENCE TO TREATMENT BY PILL COUNT AND CLINICAL OUTCOMES IN THE CHOLESTEROL AND RECURRENT EVENTS (CARE) STUDY, Circulation, 98(17), 1998, pp. 4258-4258

Authors: SACKS FM MOYE LA DAVIS BR COLE TG ROULEAU JL NASH DT PFEFFER MA BRAUNWALD E
Citation: Fm. Sacks et al., RELATIONSHIP BETWEEN PLASMA LDL CONCENTRATIONS DURING TREATMENT WITH PRAVASTATIN AND RECURRENT CORONARY EVENTS IN THE CHOLESTEROL AND RECURRENT EVENTS TRIAL, Circulation, 97(15), 1998, pp. 1446-1452

Authors: SACKS FM WUN CC COLE TG NASH DT LEPAGE S ROULEAU J MOYE LA DAVIS BR PFEFFER MA BRAUNWALD E
Citation: Fm. Sacks et al., THE INFLUENCE OF BASE-LINE LIPID-LEVELS ON REDUCTION IN CORONARY EVENTS BY PRAVASTATIN - THE CHOLESTEROL AND RECURRENT EVENTS TRIAL, Circulation, 94(8), 1996, pp. 3152-3152

Authors: NASH DT
Citation: Dt. Nash, A CONVERSATION BETWEEN 2 CARDIOLOGISTS, The American journal of cardiology, 78(7), 1996, pp. 859-859

Authors: NASH DT
Citation: Dt. Nash, MEETING NATIONAL CHOLESTEROL EDUCATION GOALS IN CLINICAL-PRACTICE - ACOMPARISON OF LOVASTATIN AND FLUVASTATIN IN PRIMARY PREVENTION, The American journal of cardiology, 78, 1996, pp. 26-31

Authors: SACKS FM ROULEAU JL MOYE LA PFEFFER MA WARNICA JW ARNOLD JMO NASH DT BROWN LE SESTIER F RUTHERFORD J DAVIS BR HAWKINS CM BRAUNWALD E
Citation: Fm. Sacks et al., BASE-LINE CHARACTERISTICS IN THE CHOLESTEROL AND RECURRENT EVENTS (CARE) TRIAL OF SECONDARY PREVENTION IN PATIENTS WITH AVERAGE SERUM-CHOLESTEROL LEVELS, The American journal of cardiology, 75(8), 1995, pp. 621-623

Authors: BRADFORD RH SHEAR CL CHREMOS AN DUJOVNE CA FRANKLIN FA GRILLO RB HIGGINS J LANGENDORFER A NASH DT POOL JL SCHNAPER H
Citation: Rh. Bradford et al., EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS - 2-YEAR EFFICACY AND SAFETY FOLLOW-UP, The American journal of cardiology, 74(7), 1994, pp. 667-673

Authors: BRADFORD RH DOWNTON M CHREMOS AN LANGENDORFER A STINNETT S NASH DT MANTELL G SHEAR CL
Citation: Rh. Bradford et al., EFFICACY AND TOLERABILITY OF LOVASTATIN IN 3390 WOMEN WITH MODERATE HYPERCHOLESTEROLEMIA, Annals of internal medicine, 118(11), 1993, pp. 850-855

Authors: MEHTA JL LOPEZ LM VLACHAKIS ND GRADMAN AH NASH DT OCONNELL MT GARLAND WT PICKERING BI
Citation: Jl. Mehta et al., DOUBLE-BLIND EVALUATION OF THE DOSE-RESPONSE RELATIONSHIP OF AMLODIPINE IN ESSENTIAL-HYPERTENSION, The American heart journal, 125(6), 1993, pp. 1704-1709

Authors: NASH DT
Citation: Dt. Nash, COMPARATIVE PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - RELATIONS WITH INHIBITION OF TISSUE ANGIOTENSIN-CONVERTING ENZYME AND POTENTIAL CLINICAL IMPLICATIONS, The American journal of cardiology, 69(10), 1992, pp. 26-32
Risultati: 1-12 |